Solence was founded by Clara Stephenson in 2022 with the mission to make personalised and patient-centric care available to all women with PCOS, the most prevalent hormonal condition among women.
Solence has raised €1.6M across 1 funding round from 6 investors, most recently a Seed round in Jul 2025. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-10 | Seed | €1.6M |
| Angel Investors,Berthe Latreille,BPI France,Céline Lazorthes,Impact Shakers Ventures,Stéphane Mardel |
| View deal → |
